Page 53 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Anticancer activity of cyanobacteria

2. Hussein HA, Abdullah MA, 2020, Anticancer compounds cyanobacterial metabolites and their screening strategies.
derived from marine diatoms. Mar Drugs, 18: 356. Biosci Biotechnol Res Asia, 19: 255–279.
https://doi.org/10.3390/md18070356 14. Pattnaik S, Singh L, 2020, Cyanobacteria bioactive
compound, their production and extraction with
3. Hussein HA, Khaphi FL, 2023, The apoptotic activity of pharmaceutical applications - a review. Int J Curr Microbiol
curcumin against oral cancer cells without affecting normal
cells in comparison to paclitaxel activity. Appl Biochem Appl Sci, 9: 3394–3405.
Biotechnol, 195: 5019–5033. 15. Sosa-Hernández JE, Escobedo-Avellaneda Z, Iqbal HMN,
et al., 2018, State-of-the-art extraction methodologies
https://doi.org/10.1007/s12010-023-04454-5
for bioactive compounds from algal biome to meet bio-
4. Salem O, El Assi R, Saleh M, 2020, Bioactive constituents economy challenges and opportunities. Molecules, 23: 2953.
of three algal species extracts and their anticancer activity https://doi.org/10.3390/molecules23112953
against human cancer cell lines. Egypt J Phycol, 21: 1–18.
16. Kumar R, Tewari AK, 2018, Medicinal properties of marine
5. Kar J, Ramrao DP, Zomuansangi R, et al., 2022, Revisiting the plants. In: Synthesis of Medicinal Agents from Plants.
role of cyanobacteria-derived metabolites as antimicrobial Netherlands: Elsevier Ltd., p257–282.
agent: A 21 century perspective. Front Microbiol, 13: 103441.
st
https://doi.org/10.1016/B978-0-08-102071-5.00011-8
https://doi.org/10.3389/fmicb.2022.1034471
17. Luesch H, Yoshida WY, Moore RE, et al., 2001, Total structure
6. Nainangu P, Antonyraj APM, Subramanian K, et al., 2020, determination of apratoxin A, a potent novel cytotoxin from
In vitro screening of antimicrobial, antioxidant, cytotoxic the marine cyanobacterium Lyngbya majuscula. J Am Chem
activities, and characterization of bioactive substances Soc, 123: 5418–5423.
from freshwater Cyanobacteria Oscillatoria sp. SSCM01
and Phormidium sp. SSCM02. Biocatal Agric Biotechnol, https://doi.org/10.1021/ja010453j
29: 101772. 18. Cai W, Chen QY, Dang LH, et al., 2017, Apratoxin S10, a
7. Khalifa SAM, Shedid ES, Saied EM, et al., 2021, dual inhibitor of angiogenesis and cancer cell growth
Cyanobacteria--from the oceans to the potential to treat highly vascularized tumors. ACS Med Chem
biotechnological and biomedical applications. Mar Drugs, Lett, 8: 1007–1012.
19: 241. https://doi.org/10.1021/acsmedchemlett.7b00192
https://doi.org/10.3390/md19050241 19. Tan LT, 2012, Marine Cyanobacteria: A treasure trove of
8. Costa M, Garcia M, Costa-Rodrigues J, et al., 2014, bioactive secondary metabolites for drug discovery. In:
Exploring bioactive properties of marine cyanobacteria Studies in Natural Products Chemistry. Vol. 36. Netherlands:
isolated from the Portuguese coast: High potential as a Elsevier, p67–110.
source of anticancer compounds. Mar Drugs, 12: 98–114. 20. Gutiérrez M, Suyama TL, Engene N, et al., 2008, Apratoxin D,
https://doi.org/10.3390/md12010098 a potent cytotoxic cyclodepsipeptide from papua new Guinea
collections of the marine Cyanobacteria Lyngbya majuscula
9. Qamar H, Hussain K, Soni A, et al., 2021, Cyanobacteria as and Lyngbya sordida. J Nat Prod, 71: 1099–1103.
natural therapeutics and pharmaceutical potential: Role in
antitumor activity and as nanovectors. Molecules, 26: 247. https://doi.org/10.1021/np800121a
https://doi.org/10.3390/molecules26010247 21. Tarsis EM, Rastelli EJ, Wengryniuk SE, et al., 2015, The
apratoxin marine natural products: Isolation, structure
10. Mehta A, Soni VK, Shukla D, et al., 2020, Cyanobacteria: determination, and asymmetric total synthesis. Tetrahedron,
A potential source of anticancer drugs. In: Advances in 71: 5029–5044.
Cyanobacterial Biology. United States: Academic Press,
p369–384. 22. Matthew S, Schupp PJ, Luesch H, 2008, Apratoxin E, a
cytotoxic peptolide from a guamanian collection of the
https://doi.org/10.1016/B978-0-12-819311-2.00024-3 marine cyanobacterium Lyngbya bouillonii. J Nat Prod,
11. Jones MR, Pinto E, Torres MA, et al., 2021, CyanoMetDB, 71: 1113–1116.
a comprehensive public database of secondary metabolites https://doi.org/10.1021/np700717s
from Cyanobacteria. Water Res, 196: 117017.
23. Thornburg CC, Cowley ES, Sikorska J, et al., 2013, Apratoxin
https://doi.org/10.1016/j.watres.2021.117017 H and Apratoxin A sulfoxide from the red sea cyanobacterium
12. Zahra Z, Choo DH, Lee H, et al., 2020, Cyanobacteria: Moorea producens. J Nat Prod, 76: 1781−1788.
Review of current potentials and applications. Environments, https://doi.org/10.1021/np4004992
7: 13.
24. Cai1 W, Ratnayake R, Gerber MH, et al., 2019, Development
13. Pooja S, Niveshika, 2022, Insight into the potential of apratoxin S10 (Apra S10) as an anti-pancreatic cancer

Volume 7 Issue 1 (2024) 10 https://doi.org/10.36922/itps.1388